A Type 1 approach to Type 2 diabetes? A pilot study comparing traditional twice-daily insulin with basal bolus and carbohydrate counting regimens

被引：0
|
作者：
Charlton, J.
Kilbride, L.
Mackay, L.
Douglas, S.
McKnight, J.
机构：
[1] Western Gen Hosp, Metab Unit, Edinburgh EH4 2XU, Midlothian, Scotland
[2] Napier Univ, Sch Nursing, Edinburgh EH14 1DJ, Midlothian, Scotland
来源：
DIABETIC MEDICINE | 2007年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [1] Switching from Twice-Daily Basal Insulin Injections to Once-Daily Insulin Degludec Injection for Basal-Bolus Insulin Regimen in Japanese Patients with Type 1 Diabetes: A Pilot Study
    Tosaka, Yuka
    Kanazawa, Akio
    Ikeda, Fuki
    Iida, Mayu
    Sato, Junko
    Matsumoto, Kazuhisa
    Uchida, Toyoyoshi
    Tamura, Yoshifumi
    Ogihara, Takeshi
    Mita, Tomoya
    Shimizu, Tomoaki
    Goto, Hiromasa
    Ohmura, Chie
    Fujitani, Yoshio
    Watada, Hirotaka
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2015, 2015
  • [2] Comparison of twice-daily injection of biphasic insulin Lispro and basal-bolus therapy in insulin naive patients with type 2 diabetes
    Yamada, Satoru
    Masuda, Haruka
    Kitaoka, Akira
    Shiono, Kaoru
    Atsuda, Koichiro
    Irie, Junichiro
    Shimada, Akira
    DIABETES, 2007, 56 : A537 - A538
  • [3] Therapeutic effectiveness of two insulin regimens for insulin naive patients with type 2 diabetes mellitus: Once-daily basal insulin or twice-daily premixed insulin?
    Sun, Peter
    Wang, Ruoping
    Jacober, Scott J.
    DIABETES, 2006, 55 : A101 - A101
  • [4] Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal–Bolus Insulin: Phase 4 OPTIMIZE Study
    Chantal Mathieu
    S. John Weisnagel
    Peter Stella
    Jacques Bruhwyler
    Kathy Alexandre
    Diabetes Therapy, 2020, 11 : 495 - 507
  • [5] Once daily insulin glargine may induce loss of basal insulin action in some patients with type 1 diabetes receiving basal bolus regimens: The need for twice daily glargine?
    Idampitiya, C
    Ward, K
    Curtis, C
    Fernando, DJS
    Idris, I
    Thomson, G
    DIABETES, 2005, 54 : A493 - A493
  • [6] Switching patients with type 1 and type 2 diabetes on basal-bolus regimen from twice-daily NPH to once-daily insulin detemir leads to improved control and safety
    Aczel, Stefan
    Hansen, Jes B.
    Tsur, Anat
    DIABETES, 2007, 56 : A544 - A544
  • [7] Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal-Bolus Insulin: Phase 4 OPTIMIZE Study
    Mathieu, Chantal
    Weisnagel, S. John
    Stella, Peter
    Bruhwyler, Jacques
    Alexandre, Kathy
    DIABETES THERAPY, 2020, 11 (02) : 495 - 507
  • [8] Daily haemodialysis and twice-daily insulin glargine to battle unstable Type 1 diabetes
    Lee, A.
    Joseph, E.
    DIABETIC MEDICINE, 2008, 25
  • [9] Twice-daily insulin glargine for patients with uncontrolled type 2 diabetes mellitus
    Eledrisi, Mohsen
    Suleiman, Noor Nabeel
    Salameh, Obada
    Hamad, Mohammad Khair
    Rabadi, Omar
    Mohamed, Ahmed
    Al Adawi, Rana
    Salam, Abdul
    JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY, 2019, 15 : 35 - 36
  • [10] COST-EFFECTIVENESS OF ADDING TWICE-DAILY EXENATIDE TO BASAL INSULIN IN PATIENTS WITH TYPE 2 DIABETES IN SCOTLAND
    Varol, N.
    Wilson, B. P.
    Norrbacka, K.
    Valentine, W. J.
    Pollock, R. F.
    VALUE IN HEALTH, 2012, 15 (07) : A500 - A500
12345